Gastrointestinal Stem Cell Biology and Gut/Liver/Pancreas Disorders

iPS-derived intestinal organoids

Stem cell models and novel stem cell-based therapies are also tested specifically for their potential to help patients suffering from target diseases treated in our expert clinical centers at Boston Medical Center, such as Familial Adenomatous Polyposis (FAP), inflammatory bowel disease (IBD: Crohn’s Disease or Ulcerative Colitis), cirrhosis of the liver, and diabetes.

Mouse iPS Cell Colonies

Mouse iPS Cell Colonies

To learn more, please click on the webpages of one of our investigators studying gastrointestinal stem cells and gastrointestinal epithelial injury and repair:

Contact|Directory|BUMC
December 27, 2012
Primary teaching affiliate
of BU School of Medicine